Founder & Chief Executive Officer
Biograil ApS
Roskilde, Denmark
Karsten has more than 25 years of experience in the pharmaceutical industry and CEO/founder of Biograil developing a drug delivery technology for effective oral delivery of biomacromolecules and has established collaborations with Eli Lilly and CSL Behring. Karsten when he was CSO of the US public company Egalet and part of his current team were responsible for the world’s first injection molded oral product Arymo ER to get FDA approval. Karsten is also the co-founder of Scantox, a non-clinical CRO and panel member of Innovation Fund Denmark.
Disclosure information not submitted.
BIONND™, a Drug Delivery Technology for Efficient Oral Administration of Peptides and Biologics
Monday, July 14, 2025
3:30 PM - 4:00 PM EDT
